[144] Vita Coco Company, Inc. SEC Filing
Rhea-AI Filing Summary
Vita Coco Company, Inc. (COCO) filing a Form 144 notifies the proposed sale of 10,000 common shares through Morgan Stanley Smith Barney on 09/17/2025 with an aggregate market value of $399,800.00. The shares were acquired and paid for on 09/17/2025 by exercise of stock options, with payment in cash. The filer also reported three prior 10b5-1 sales this year totaling 30,000 shares on 06/18/2025, 07/01/2025 and 09/12/2025, with gross proceeds shown for each sale.
Positive
- None.
Negative
- None.
Insights
TL;DR Routine insider option exercise and planned sale; transaction size appears modest versus typical public floats.
The filing documents the exercise of stock options and a concurrent proposed sale of 10,000 common shares via a broker at an indicated market value of $399,800. Cash was used to pay for the exercise on the same date. The record of multiple 10b5-1 sales earlier in the year suggests prearranged trading plans have been used. For investors, this is a disclosure of insider liquidity actions rather than an operational update.
TL;DR Filing reflects compliance with Rule 144 and use of 10b5-1 plans; no explicit adverse governance signals disclosed.
The submitter affirms the representation required under the form that no undisclosed material adverse information exists. The combination of an option exercise followed by planned sales and prior 10b5-1 transactions is consistent with routine insider liquidity management. The presence of a named broker and explicit dates supports regulatory completeness of the notice.